FERTILITY CAPSULE IV (FSH, LH, PROLACTIN, TESTOSTERONE)

Fertility Capsule IV is a blood-test panel that measures Follicle-Stimulating Hormone (FSH), Luteinizing Hormone (LH), prolactin and testosterone. These hormones provide information about pituitary, ovarian and testicular function. They participate in menstrual-cycle regulation, ovulation, testosterone production, sexual function and sperm development.

FSH, LH and prolactin are produced by the pituitary gland. In females, FSH supports ovarian follicle development, while LH helps trigger ovulation and supports ovarian hormone production. In males, FSH supports sperm production and LH stimulates the testes to produce testosterone. Prolactin may interfere with normal reproductive signalling when persistently elevated outside pregnancy or breastfeeding.

Testosterone is produced primarily by the testes in males and in smaller quantities by the ovaries and adrenal glands in females. It contributes to sexual function, reproductive health, muscle and bone maintenance and the development of sex-related physical characteristics. Abnormal testosterone may affect reproductive function in both sexes.

This panel supports hormonal fertility evaluation but cannot confirm overall fertility independently. It does not directly assess sperm count or movement, egg quality, ovarian reserve, ovulation, fallopian-tube patency or reproductive anatomy. Results must be interpreted with sex, age, symptoms, collection time, menstrual-cycle phase and additional investigations.

Benefits of the Test

• Measures four important reproductive and pituitary hormones.
• Supports hormonal evaluation of male and female fertility difficulties.
• Helps assess ovarian and testicular hormone signalling.
• May help investigate irregular or absent menstrual periods.
• Supports evaluation of suspected pituitary or hypothalamic dysfunction.
• Assesses prolactin-related factors that may interfere with reproductive function.
• Measures testosterone for evaluation of androgen deficiency or excess.
• May contribute to the investigation of low sperm count or male hypogonadism.
• Provides multiple related hormone results from one blood collection.

Why Doctors Recommend This Test

A doctor may recommend Fertility Capsule IV when a couple is experiencing difficulty conceiving or when an individual has symptoms suggesting a reproductive hormone imbalance. The panel can provide information about the communication between the pituitary gland and the ovaries or testes.

In females, FSH promotes the growth of ovarian follicles. LH contributes to final follicle maturation and helps trigger ovulation through a mid-cycle surge. Abnormal values may occur with ovarian dysfunction, menopause, PCOS or disorders affecting the hypothalamus or pituitary gland. These results must be interpreted according to menstrual-cycle timing.

In males, FSH supports the cells involved in sperm development, while LH stimulates testosterone production. Increased FSH may occur when sperm-producing testicular function is impaired. Low FSH or LH may indicate insufficient stimulation from the pituitary or hypothalamus. A semen analysis is still necessary because hormone testing does not measure sperm directly.

Prolactin may be assessed when a patient has infertility, irregular or absent periods, unexpected breast-milk production, reduced sexual desire or erectile difficulties. Persistently elevated prolactin may suppress FSH, LH and sex-hormone production. Pregnancy, breastfeeding, medicines, hypothyroidism and pituitary conditions are among the possible causes.

In adult males, testosterone testing may support evaluation of reduced libido, erectile problems, decreased morning erections, loss of muscle mass, reduced body hair, infertility or delayed puberty. A low result usually requires confirmation with another appropriately timed morning sample before a diagnosis is established.

In females, increased testosterone may be associated with acne, excess facial or body hair, scalp hair thinning, irregular periods or PCOS. Less common ovarian or adrenal causes may also be considered when concentrations are markedly increased or symptoms progress rapidly.

Preparation Before Test

A venous blood sample is collected from a vein in the arm. Fasting is not always required solely for these four hormones. However, morning fasting collection may be advised depending on the clinical purpose and other investigations ordered. Follow the specific instructions provided by the doctor or Focus Diagnostics.

For adult males undergoing evaluation of possible testosterone deficiency, morning sample collection is generally preferred because testosterone commonly reaches its highest concentration earlier in the day. Acute illness, inadequate sleep, substantial calorie restriction and strenuous physical stress may temporarily lower testosterone.

Female patients should inform the doctor and laboratory about the first day of the last menstrual period and usual cycle length. FSH and LH change considerably during the menstrual cycle. For baseline assessment, these hormones may be requested during the early follicular phase, commonly around cycle days 2 to 5.

Prolactin varies throughout the day and may rise temporarily because of sleep, emotional stress, pain, strenuous exercise, sexual activity or nipple stimulation. A doctor may recommend morning collection a few hours after waking and a short period of quiet rest before sample collection.

Inform the doctor about all prescribed medicines, non-prescription medicines, vitamins, protein products and supplements. Fertility medicines, hormonal contraception, estrogen, progesterone, testosterone, anabolic steroids, antipsychotics, antidepressants, anti-nausea medicines, opioids and several other treatments may affect one or more results.

Biotin supplements can interfere with certain laboratory immunoassays. Do not stop biotin or any prescribed treatment without instructions from the doctor or laboratory. Patients receiving testosterone treatment should provide the product name, dose, route and exact time of the most recent dose.

Tell the healthcare professional about pregnancy, breastfeeding, menopause, PCOS, pituitary disease, thyroid disease, testicular or ovarian surgery, recent serious illness and current fertility treatment. These factors may alter hormone concentrations or their interpretation.

Normal Reporting Time

Fertility Capsule IV is generally reported on the same day or within 24 to 48 hours after the laboratory receives an acceptable blood sample. The exact turnaround time depends on the laboratory's testing schedule and the analytical method used for testosterone.

Reporting may take longer when testosterone is measured through a specialised method, the sample is referred to another laboratory, or a result requires dilution, repeat analysis or quality verification. Patients requiring results before a fertility appointment should confirm the expected reporting time with the collection centre.

Clinical interpretation may require additional time if a borderline testosterone or mildly elevated prolactin result must be confirmed using another appropriately prepared sample.

Who Should Take This Test?

This panel may be recommended for males undergoing fertility evaluation, especially when semen analysis shows a low sperm count or when symptoms suggest testosterone deficiency. It may also be appropriate for men with reduced sexual desire, erectile difficulties, reduced body hair, decreased muscle mass or delayed puberty.

Females experiencing difficulty becoming pregnant, irregular periods, absent periods or suspected ovulatory dysfunction may also require FSH, LH and prolactin testing. Testosterone can provide additional information when symptoms of androgen excess are present.

Women with excess facial or body hair, persistent acne, scalp hair thinning or menstrual irregularity may be advised to undergo testosterone testing as part of an assessment for PCOS or another androgen-related condition. This panel cannot diagnose PCOS by itself.

People with unexpected nipple discharge, headaches, vision changes or persistently elevated prolactin may require pituitary assessment. These symptoms should be reviewed promptly by a doctor and should not be evaluated using laboratory results alone.

Patients with suspected hypothalamic or pituitary dysfunction may require this panel because FSH, LH and prolactin are produced by the pituitary gland. Additional tests may include TSH, free T4, cortisol, estradiol, SHBG or pituitary imaging.

This panel is not required as routine fertility screening for everyone. The appropriate investigations depend on the patient's sex, age, symptoms, reproductive history and clinical examination.

Understanding the Hormones

Follicle-Stimulating Hormone: FSH is produced by the pituitary gland. In females, it supports the growth of ovarian follicles. An increased early-cycle FSH result may be associated with reduced ovarian response or ovarian insufficiency. A normal FSH value cannot guarantee normal ovarian reserve.

In males, FSH supports sperm-producing cells in the testes. Increased FSH may occur when testicular sperm production is impaired, while low FSH may indicate insufficient pituitary or hypothalamic stimulation. Semen analysis is required to assess sperm concentration, motility and morphology directly.

Luteinizing Hormone: In females, LH helps trigger ovulation and supports ovarian hormone production. Its concentration changes across the menstrual cycle and rises during the pre-ovulatory surge. A single LH measurement cannot reliably confirm whether ovulation occurred.

In males, LH stimulates the testes to produce testosterone. Low testosterone accompanied by increased LH may suggest reduced testicular response. Low testosterone with low or inappropriately normal LH may indicate a hypothalamic or pituitary cause.

Prolactin: Prolactin supports breast development and milk production. Persistently elevated prolactin outside pregnancy or breastfeeding may suppress reproductive hormone signalling and contribute to infertility, menstrual disturbance, low testosterone or sexual dysfunction.

A mildly increased prolactin result may be temporary. The doctor may recommend repeat testing after adequate rest. Depending on the result and symptoms, pregnancy testing, thyroid evaluation, medicine review, macroprolactin testing or pituitary imaging may be required.

Testosterone: Testosterone supports reproductive and sexual function in both sexes. Total testosterone includes hormone bound to SHBG, hormone weakly bound to albumin and a small free fraction. When SHBG is abnormal, total testosterone may not reflect the amount readily available to tissues.

A borderline or inconsistent result may require repeat morning total testosterone, SHBG, albumin, calculated free testosterone or bioavailable testosterone. Treatment decisions should not be based on one isolated value.

Detailed Information

The reproductive hormone system begins with the hypothalamus, which signals the pituitary gland to release FSH and LH. These hormones act on the ovaries or testes. Hormones produced by the reproductive organs then provide feedback to the brain and pituitary gland, helping regulate the system.

Doctors interpret FSH, LH and testosterone as a pattern. In males, low testosterone with increased FSH or LH may indicate primary testicular dysfunction. Low testosterone with low FSH and LH may suggest secondary hypogonadism caused by pituitary, hypothalamic or systemic factors.

In females, FSH and LH vary significantly according to the menstrual-cycle phase. Values expected in the follicular phase differ from those during ovulation, the luteal phase and menopause. The collection day should therefore be recorded whenever applicable.

An increased LH-to-FSH ratio may be observed in some patients with PCOS, but the ratio cannot establish the diagnosis. PCOS assessment requires symptoms, menstrual history and exclusion of other causes, and may include ultrasound and additional laboratory tests.

High prolactin may reduce the secretion of reproductive hormones. However, stress-related elevations and macroprolactin can complicate interpretation. A high result should be assessed with symptoms, medicines, pregnancy status and thyroid function.

Testosterone varies throughout the day and from one day to another. Low values during acute illness may not represent the patient's usual hormonal condition. Adult male testosterone deficiency is generally diagnosed only when symptoms are present and low levels are confirmed on appropriately timed testing.

A normal hormone panel does not exclude fertility problems. Female evaluation may additionally require AMH, estradiol, progesterone, pelvic ultrasound, ovulation assessment, tubal-patency testing and uterine evaluation. Male assessment commonly requires semen analysis and physical examination.

Reference intervals vary according to sex, age, pubertal stage, menstrual phase and laboratory method. Patients should use the ranges printed on their Focus Diagnostics report rather than comparing their results with another laboratory or an online chart.

An abnormal result does not automatically indicate permanent infertility or establish a need for hormonal treatment. Testosterone therapy can suppress sperm production and may be inappropriate for a man currently planning fertility. No fertility medicine, testosterone product or hormonal supplement should be started or changed without professional medical advice.